These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9465949

  • 1. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D, Schüller H, Textor J, Leutner C, Keller E, Sommer T, Träber F, Block W, Boldt I, Schild H.
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
    Hosten N, Schörner W, Lietz A, Wenzel KW.
    Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Graves ophthalmopathy: MR imaging of the orbits.
    Hosten N, Sander B, Cordes M, Schubert CJ, Schörner W, Felix R.
    Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
    Hosten N, Cordes M, Sander B, Schörner W, Wenzel KW, Felix R.
    Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
    Utech CI, Khatibnia U, Winter PF, Wulle KG.
    Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Graves' disease of the orbit.
    Weber AL, Dallow RL, Sabates NR.
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].
    Pedrosa P, Pfannenstiel P, Just M, Higer HP, Utech C, Brederhoff J, Wulle KG.
    Klin Monbl Augenheilkd; 1988 Aug; 193(2):169-73. PubMed ID: 3184751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
    Nakahara H, Noguchi S, Murakami N, Morita M, Tamaru M, Ohnishi T, Hoshi H, Jinnouchi S, Nagamachi S, Futami S.
    Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
    [Abstract] [Full Text] [Related]

  • 17. Graves orbitopathy: correlation of CT and clinical findings.
    Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, Graeb DA.
    Radiology; 1990 Dec; 177(3):675-82. PubMed ID: 2243967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE, Lee CP, Muramatsu SK, Weiner JM.
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.